|
|
|
|
|||||
|
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost  |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| MASI | Sampath Anand | EVP, Ops & Clinical Research | Jan 28 '26 | Option Exercise | 37.84 | 30,000 | 1,135,200 | 59,589 | Jan 30 08:13 PM |
| MASI | Sampath Anand | EVP, Ops & Clinical Research | Jan 28 '26 | Sale | 136.81 | 18,680 | 2,555,570 | 40,909 | Jan 30 08:13 PM |
| MASI | Sampath Anand | Officer | Jan 28 '26 | Proposed Sale | 136.81 | 18,680 | 2,555,567 | Jan 28 04:00 PM | |
| MASI | Sampath Anand | EVP, Ops & Clinical Research | Jan 02 '21 | Option Exercise | 0.00 | 2,000 | 0 | 15,782 | Jan 06 04:08 PM |
| MASI | Sampath Anand | EVP, Ops & Clinical Research | Dec 15 '20 | Option Exercise | 26.39 | 30,000 | 791,700 | 28,782 | Dec 17 05:23 PM |
| MASI | Sampath Anand | EVP, Ops & Clinical Research | Dec 15 '20 | Sale | 265.59 | 30,000 | 7,967,805 | 13,782 | Dec 17 05:23 PM |
| MASI | Sampath Anand | EVP, Ops & Clinical Research | Apr 13 '20 | Option Exercise | 21.77 | 19,796 | 430,959 | 33,578 | Apr 15 04:15 PM |
| MASI | Sampath Anand | EVP, Ops & Clinical Research | Apr 13 '20 | Sale | 180.00 | 19,796 | 3,563,280 | 13,782 | Apr 15 04:15 PM |
| MASI | Sampath Anand | EVP, Ops & Clinical Research | Jan 02 '20 | Option Exercise | 0.00 | 2,000 | 0 | 14,518 | Jan 06 04:12 PM |
| MASI | Sampath Anand | EVP, Ops & Clinical Research | Nov 20 '19 | Option Exercise | 31.01 | 15,000 | 465,150 | 27,518 | Nov 21 04:12 PM |
| MASI | Sampath Anand | EVP, Ops & Clinical Research | Nov 20 '19 | Sale | 155.00 | 15,000 | 2,325,002 | 12,518 | Nov 21 04:12 PM |
| MASI | Sampath Anand | EVP, Ops & Clinical Research | Jun 14 '19 | Option Exercise | 28.03 | 30,000 | 840,900 | 27,518 | Jun 18 04:27 PM |
| MASI | Sampath Anand | EVP, Ops & Clinical Research | Jun 14 '19 | Sale | 142.38 | 30,000 | 4,271,550 | 12,518 | Jun 18 04:27 PM |
| MASI | Sampath Anand | Chief Operating Officer | Jan 15 '19 | Option Exercise | 21.97 | 30,000 | 659,100 | 42,518 | Jan 16 04:10 PM |
| MASI | Sampath Anand | Chief Operating Officer | Jan 15 '19 | Sale | 115.00 | 30,000 | 3,450,000 | 12,518 | Jan 16 04:10 PM |
| MASI | Sampath Anand | Chief Operating Officer | Jan 02 '19 | Option Exercise | 0.00 | 2,000 | 0 | 13,272 | Jan 04 04:27 PM |
| MASI | Sampath Anand | Chief Operating Officer | Nov 28 '18 | Option Exercise | 20.19 | 30,000 | 605,700 | 41,272 | Nov 30 04:19 PM |
| MASI | Sampath Anand | Chief Operating Officer | Nov 28 '18 | Sale | 110.00 | 30,000 | 3,300,000 | 11,272 | Nov 30 04:19 PM |
| MASI | Sampath Anand | Chief Operating Officer | Feb 27 '18 | Option Exercise | 0.00 | 2,000 | 0 | 12,000 | Mar 01 09:02 PM |
| MASI | Sampath Anand | Chief Operating Officer | Jul 11 '17 | Option Exercise | 28.71 | 40,000 | 1,148,600 | 40,000 | Jul 13 04:34 PM |
| MASI | Sampath Anand | Chief Operating Officer | Jul 11 '17 | Sale | 92.00 | 40,000 | 3,680,000 | 10,000 | Jul 13 04:34 PM |
| MASI | Sampath Anand | Chief Operating Officer | Jan 12 '17 | Option Exercise | 14.22 | 10,000 | 142,200 | 10,000 | Jan 12 04:54 PM |
| MASI | Sampath Anand | Chief Operating Officer | Oct 31 '16 | Option Exercise | 14.22 | 51,345 | 730,126 | 28,174 | Nov 02 05:22 PM |
| MASI | Sampath Anand | Chief Operating Officer | Nov 01 '16 | Option Exercise | 14.22 | 13,655 | 194,174 | 13,655 | Nov 02 05:22 PM |
| MASI | Sampath Anand | Chief Operating Officer | Nov 01 '16 | Sale | 55.00 | 13,655 | 751,025 | 0 | Nov 02 05:22 PM |
| MASI | Sampath Anand | Chief Operating Officer | Oct 31 '16 | Sale | 55.05 | 51,345 | 2,826,658 | 0 | Nov 02 05:22 PM |
| MASI | Sampath Anand | Chief Operating Officer | Nov 06 '15 | Option Exercise | 11.11 | 45,000 | 500,100 | 30,000 | Nov 10 04:49 PM |
| MASI | Sampath Anand | Chief Operating Officer | Nov 06 '15 | Sale | 42.00 | 45,000 | 1,890,000 | 0 | Nov 10 04:49 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite